Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin peptide receptor system.

Biotechnology

Pharmaceutical

Palatin Technologies

Palatin Technologies' headquarters in Cranbury, NJ, United States

Carl Spana

Alison Obr, Ph.D.

Johna Lucas

Don Wang

J. Don Wang

James E. Hattersley

Michael B. Raizman

Stephen A. Slusher

Stephen T. Wills

J. Stanley Hull

Stanley Hull

Robert K. deVeer

Arlene M. Morris

John K.A. Prendergast

Alan W. Dunton

Anthony M. Manning

This department oversees organizational strategy and decision-making responsibilities.

Leadership Council

The Clinical Operations and Regulatory Affairs team at Palatin Technologies is responsible for overseeing the planning, execution, and management of clinical trials to evaluate the efficacy and safety of the company's innovative therapies. This team ensures compliance with regulatory requirements and works closely with health authorities to navigate the approval process for new medicines, while also maintaining quality assurance throughout all clinical operations.

Clinical Operations and Regulatory Affairs

This department focuses on the research and development of new therapeutic drugs.

Drug Discovery

The Leadership Team at Palatin Technologies is responsible for setting the strategic direction and overall vision of the company. This team comprises key executives who oversee various functions such as product development, business development, regulatory affairs, and preclinical research, ensuring alignment with the company's mission to develop innovative biopharmaceuticals. Their collaborative efforts drive decision-making, resource allocation, and the cultivation of partnerships to advance novel therapies targeting melanocortin peptide receptors.

Leadership Team

This department oversees medical strategies and initiatives within the organization.

Medical Leadership

The Research and Development team at Palatin Technologies focuses on the discovery and optimization of innovative therapeutics that target the melanocortin peptide receptor system. Comprising experts in drug characterization, bioinformatics, and various scientific disciplines, the team conducts cutting-edge research to advance novel biopharmaceutical candidates from concept through preclinical development, ensuring efficacy, safety, and potential for leading-edge patient treatments.

Palatin Technologies

Org chart

Board & advisors

Teams

Leadership Council

Clinical Operations and Regulatory Affairs

Drug Discovery

Leadership Team

Medical Leadership

Research and Development

Offices

Palatin Technologies

Org chart

Board & advisors

Teams

Leadership Council

Clinical Operations and Regulatory Affairs

Drug Discovery

Leadership Team

Medical Leadership

Research and Development

Offices

Related companies